1. Home
  2. AMS vs TRIB Comparison

AMS vs TRIB Comparison

Compare AMS & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

N/A

Current Price

$2.09

Market Cap

13.9M

Sector

Health Care

ML Signal

N/A

TRIB

Trinity Biotech plc

N/A

Current Price

$0.70

Market Cap

14.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMS
TRIB
Founded
1980
1992
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
14.0M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
AMS
TRIB
Price
$2.09
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.8K
155.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
230.00
N/A
EPS
N/A
N/A
Revenue
$19,714,000.00
N/A
Revenue This Year
$3.81
$13.51
Revenue Next Year
N/A
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
0.81
N/A
52 Week Low
$2.02
$0.48
52 Week High
$3.11
$3.44

Technical Indicators

Market Signals
Indicator
AMS
TRIB
Relative Strength Index (RSI) 43.91 42.10
Support Level $2.04 $0.64
Resistance Level $2.19 $0.70
Average True Range (ATR) 0.06 0.05
MACD -0.01 0.00
Stochastic Oscillator 23.14 52.47

Price Performance

Historical Comparison
AMS
TRIB

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: